McKinsey September 10, 2021
Shubham Singhal, Patrick Finn, and Jeris Stueland

Employers have rapidly adapted during the COVID-19 pandemic: Can they now apply that level of speed to innovating employer-sponsored insurance?

Poor health costs the US economy about $3.2 trillion annually from premature deaths and the lost productive potential associated with diseases. Compared with high-income peer countries, the United States has a 46 to 50 percent higher disease burden rate for 20- to 40-year-old workers, and a 17 to 33 percent higher disease burden rate for those over 40 years old. Through known interventions alone (requiring no new innovations), we could add 10 years of productive life to American workers.1

Making employer-sponsored healthcare work better for America’s workers, then, is a moral and economic imperative at the societal level. High inflation...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Employer, Healthcare System, Insurance, Medicare Advantage, Patient / Consumer, Payer, Provider, Public Health / COVID, Self-insured
How are employers going to pay for cell and gene therapies?
The Cost of Healthcare
Employers sue to block mental health parity regulations
A CEO's Blueprint For Innovation And Resilience In 2025
Understanding The Long-Term Decline Of The Small-Group Health Insurance Market

Share This Article